Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
12 hedge funds and large institutions have $652K invested in Genetic Technologies Ltd. in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
32% more capital invested
Capital invested by funds: $492K → $652K (+$159K)
20% more funds holding
Funds holding: 10 → 12 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
14% less call options, than puts
Call options by funds: $185K | Put options by funds: $216K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$199K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$52.9K |
| 3 |
VF
Virtu Financial
New York
|
+$23.3K |
| 4 |
Morgan Stanley
New York
|
+$20.3K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$19.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$242K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$22.4K |
| 3 |
CG
Cutler Group
San Francisco,
California
|
-$1.12K |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$1K |
GENE Hedge Fund Activity: Q3 2020 in Review
12 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2020, worth a combined $652K — up 32% from $492K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GENE positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $199K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $242K sold.
- 12 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2020, up from 10 in Q2 2020.
- Funds reported $652K of Genetic Technologies Ltd. stock for Q3 2020, up 32% quarter-over-quarter.
- 5 funds opened new Genetic Technologies Ltd. positions in Q3 2020 and 2 closed out, a net change of +3 holders.
- The largest Genetic Technologies Ltd. buyer in Q3 2020 was Susquehanna International Group, an estimated $199K added.
- The largest Genetic Technologies Ltd. seller in Q3 2020 was Renaissance Technologies, an estimated $242K sold.
Based on aggregated 13F filings for Q3 2020.